Remibrutinib, a BTK inhibitor, offers a new oral treatment for chronic spontaneous urticaria, providing an alternative to traditional therapies. Experts discuss groundbreaking therapies in dermatology ...

Danish dermatology specialist Leo Pharma and its CEO Christophe Bourdon came to San Francisco to attend the J.P. Morgan Healthcare Conference for a specific reason. “I know the power of addressing ...

More than one-third of patients with cutaneous chronic graft-versus-host disease had a perception of treatment response that ...

A Maui Derm 2026 session explored advancements in pediatric dermatology, emphasizing precision medicine and targeted therapies for children.

Almirall's dermatology focus will get a boost with a new skin disease awareness campaign. The Barcelona-based pharma’s digital work called the “Shared Skin Initiative” features 5 Almirall employees ...

Leo Pharma’s bold commitment to be a strong player in the dermatological space was made clear at the JP Morgan Healthcare Conference 2026. The CEO, Christophe Bourdon, discussed that he was there to ...

A recent study published in JAMA Dermatology has demonstrated that PROMIS measures are valid tools for evaluating the physical, emotional, and social effects of chronic skin diseases.

The mission of the Skin Diseases Research Center (SDRC) is to add value to our investigators through strength of focus on uniting basic and translational skin science. The vision of the SDRC is: The ...

Dermatology in the near future will be characterized by digitally enabled, patient-centred research that reaches people where ...

Please provide your email address to receive an email when new articles are posted on . A study presented at the American Academy of Dermatology virtual meeting associated several risk factors for ...

DUBLIN, April 1, 2021 /PRNewswire/ -- The "Dermatology Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering. This report ...